Operations Core

运营核心

基本信息

项目摘要

OPERATIONS CORE ABSTRACT: The Regional Biocontainment Laboratory (RBL) within the Center for Vaccine Research (CVR) at the University of Pittsburgh is the biosafety level-3 (BSL-3) hub for infection biology. The mission of the RBL is threefold, to work on pathogen emergence, evolution and host-to-host transmission, to study the pathogenesis of emerging infectious diseases and to accelerate pre-clinical development of novel interventions and medical countermeasures for pandemic preparedness and biodefense. Our vision is to be a globally recognized, highly- collaborative, creative and forward-facing team of infection biologists who are poised to respond to emerging biological threats both at the national and international level. The entire facility is registered with the Division of Select Agents and Toxins (DSAT). It brings together infection biologists and clinicians from a variety of disciplines who require BSL-3 and animal (A)BSL-3 facilities for their wide ranging viral and bacterial research programs. The Operations Core will be responsible for the formal operationalization and development of our existing structures. These have evolved from the time the RBL was established, and although they have served their purpose, require modernization to ensure they will remain current and operationally fit-for-purpose. Biocontainment work is operationally complex, infrastructure-dense, and comprehensively regulated. Running BSL-3 laboratories safely, securely and successfully demands having a well-organized and highly integrated team of administrators, scientists, biosafety/biosecurity professionals, engineers/facilities staff and veterinarians/zootechnical staff. This is especially important in multi-pathogen, multi-user research facilities that study standard and select agent BSL-3 pathogens. The Operations Core will provide overall management and budgetary responsibility for the RBL. It will administer the daily, weekly, monthly and yearly BSL-3 activities essential for the support and services arms of the RBL to function. This will ensure that the BSL-3 laboratories are run and maintained at the highest standards and they are safe and secure. Operational support for the RBL in Pittsburgh will ensure we are ready to support any national response to a range of emerging infectious diseases in the event of another pandemic or bioterrorism attack. Supporting this cohort of BSL-3 scientists, who can pivot to work on new pathogens in an emergency, is certain to pay dividends.
运营核心 摘要: 该大学疫苗研究中心(CVR)内的区域生物防护实验室(RBL) 匹兹堡大学是生物安全3级(BSL-3)感染生物学中心。RBL的使命有三个方面, 致力于病原体的出现、进化和宿主间传播,研究 新出现的传染病,并加快新的干预措施和医疗 预防大流行和生物防御的对策。我们的愿景是成为一个全球公认的,高度- 协作,创造性和前瞻性的感染生物学家团队谁是准备应对新出现的 在国家和国际一级的生物威胁。整个设施都已在 选择代理和毒素(DSAT)。它汇集了来自不同学科的感染生物学家和临床医生 他们需要BSL-3和动物(A)BSL-3设施进行广泛的病毒和细菌研究计划。 运营核心将负责我们现有的 结构.这些都是从RBL成立的时候演变而来的,虽然他们已经为他们的 为了达到这一目的,需要进行现代化,以确保它们保持最新状态,并在业务上适合这一目的。 生物防护工作操作复杂,基础设施密集,监管全面。运行 BSL-3实验室的安全,可靠和成功的要求有一个组织良好,高度集成 管理人员、科学家、生物安全/生物安保专业人员、工程师/设施工作人员和 兽医/动物技术人员。这在多病原体、多用户研究设施中尤其重要, 研究BSL-3病原体标准和筛选。业务核心将提供全面管理, 对RBL的预算责任。它将管理每日、每周、每月和每年的BSL-3活动 这对RBL的支持和服务部门发挥作用至关重要。这将确保BSL-3实验室 以最高标准运行和维护,并且安全可靠。对区域预算清单的业务支助 在匹兹堡举行的会议将确保我们准备好支持任何国家对一系列新出现的传染病的反应。 在另一次大流行或生物恐怖袭击的情况下,支持这一组BSL-3科学家,他们 可以在紧急情况下转向研究新的病原体,这肯定会带来回报。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William Paul Duprex其他文献

William Paul Duprex的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William Paul Duprex', 18)}}的其他基金

Pitt RBL
皮特·RBL
  • 批准号:
    10793942
  • 财政年份:
    2023
  • 资助金额:
    $ 98.46万
  • 项目类别:
Integrated Services Core
综合服务核心
  • 批准号:
    10793945
  • 财政年份:
    2023
  • 资助金额:
    $ 98.46万
  • 项目类别:
Practices Core
实践核心
  • 批准号:
    10793944
  • 财政年份:
    2023
  • 资助金额:
    $ 98.46万
  • 项目类别:
Administrative Supplement for Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research
升级匹兹堡大学疫苗研究中心区域生物防护实验室的行政补充
  • 批准号:
    10631339
  • 财政年份:
    2022
  • 资助金额:
    $ 98.46万
  • 项目类别:
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
开发用于中和 SARS-CoV-2 的多价、超强纳米抗体混合物
  • 批准号:
    10444442
  • 财政年份:
    2022
  • 资助金额:
    $ 98.46万
  • 项目类别:
Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research
升级疫苗研究中心内的匹兹堡大学区域生物防护实验室
  • 批准号:
    10394474
  • 财政年份:
    2021
  • 资助金额:
    $ 98.46万
  • 项目类别:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
转变疫苗安全范式:从经验衰减到理性衰减
  • 批准号:
    8664340
  • 财政年份:
    2013
  • 资助金额:
    $ 98.46万
  • 项目类别:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
转变疫苗安全范式:从经验衰减到理性衰减
  • 批准号:
    8504483
  • 财政年份:
    2013
  • 资助金额:
    $ 98.46万
  • 项目类别:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
转变疫苗安全范式:从经验衰减到理性衰减
  • 批准号:
    9064740
  • 财政年份:
    2013
  • 资助金额:
    $ 98.46万
  • 项目类别:
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation
转变疫苗安全范式:从经验衰减到理性衰减
  • 批准号:
    8852530
  • 财政年份:
    2013
  • 资助金额:
    $ 98.46万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 98.46万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 98.46万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 98.46万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 98.46万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 98.46万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 98.46万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 98.46万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 98.46万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 98.46万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 98.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了